Organization
Jennifer Lee Caswell-Jin
1 clinical trial
Clinical trial
A Phase 1B Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast CancerStatus: Terminated, Estimated PCD: 2021-10-22